GSKCH announcements GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare (GSKCH) has 100 notices stored from the exchange, from 29 Apr 2020 to 06 Jan 2023. The newest is dated 06 Jan 2023; the titles below are the exchange’s own words.
Every notice stored, newest first
| Date | Kind | Title as filed | |
|---|---|---|---|
| 06 Jan 2023 | Announcement | Approval of Company Name Change - Haleon Pakistan Limited | |
| 05 Dec 2022 | Board meeting | Results of the Board of Directors Meeting Other than Financial Results | |
| 05 Dec 2022 | General meeting | CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022 | |
| 25 Nov 2022 | Board meeting | Notice of Board Meeting Other Than Financial Results | |
| 14 Nov 2022 | General meeting | Notice of Extraordinary General Meeting - 2022 | |
| 11 Nov 2022 | General meeting | Prior Publication of Extraordinary General Meeting Notice - 2022 | |
| 10 Nov 2022 | Management change | Material Information - Appointment of Non-Executive Director | |
| 04 Nov 2022 | Announcement | Lifting of Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range | |
| 02 Nov 2022 | Corporate briefing | Notice of Corporate Briefing Session 2022 - Revised Date | |
| 27 Oct 2022 | Corporate briefing | Notice of Corporate Briefing Session - 2022 | |
| 27 Oct 2022 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30 September 2022 | |
| 21 Oct 2022 | Announcement | Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range | |
| 21 Oct 2022 | Financial results | Financial Results for the Quarter Ended 30 September 2022 | |
| 13 Oct 2022 | Board meeting | Notice of Board of Directors Meeting - (Q3-2022) | |
| 16 Sep 2022 | Material information | Panadol - Material Information | |
| 29 Aug 2022 | Report sent to shareholders | Transmission of Half Yearly Report for the Period Ended 30 June 2022 | |
| 24 Aug 2022 | Announcement | Notice of Update in Email Address for Shareholders | |
| 23 Aug 2022 | Announcement | BoD Approval of Change of Company Name | |
| 23 Aug 2022 | Financial results | Financial Results for the Quarter Ended 30 June 2022 | |
| 15 Aug 2022 | Board meeting | Notice of Board of Directors Meeting - (Q2-2022) | |
| 29 Jul 2022 | Restructuring | Demerger of Haleon plc and Change in Ultimate Parent of the Company | |
| 22 Jun 2022 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 16 Jun 2022 | Announcement | Notice of Change in Email Address for Shareholders | |
| 15 Jun 2022 | Restructuring | Reminder for Mandatory Conversion of Physical Shares to Book-Entry Form | |
| 14 Jun 2022 | Administrative notice | Change in Registered Office Address | |
| 14 Jun 2022 | Restructuring | Prior Publication of Conversion of Physical Shares to Book Entry Form | |
| 20 May 2022 | Material information | Material Information | |
| 27 Apr 2022 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 31 March 2022 | |
| 25 Apr 2022 | Financial results | Financial Results for the Quarter Ended 31 March 2022 | |
| 22 Apr 2022 | Board meeting | Board Meeting in Progress | |
| 14 Apr 2022 | Board meeting | Notice of Board of Directors Meeting - (Q1-2022) | |
| 31 Mar 2022 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 22 Mar 2022 | Management change | Re-appointment of Chairperson and Chief Executive Officer | |
| 21 Mar 2022 | General meeting | CTC of Resolutions Passed in the Annual General Meeting 2021 | |
| 14 Mar 2022 | General meeting | Notice of Election of Directors | |
| 11 Mar 2022 | General meeting | Prior Publication of Notice of Election of Directors | |
| 28 Feb 2022 | General meeting | Notice of Annual General Meeting - 2021 | |
| 28 Feb 2022 | Report sent to shareholders | Transmission of the Annual Report for the Year Ended 2021 | |
| 25 Feb 2022 | General meeting | Prior Publication of AGM Notice for the year 2021 | |
| 09 Feb 2022 | Financial results | Financial Results for the Year Ended 31 December 2021 | |
| 03 Feb 2022 | Board meeting | Board of Directors Meeting - (Q4-2021) | |
| 02 Feb 2022 | Board meeting | 23rd Board of Directors Meeting REVOKED | |
| 24 Dec 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 11 Nov 2021 | Corporate briefing | Notice of Corporate Briefing Session 2021 | |
| 29 Oct 2021 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30 September 2021 | |
| 26 Oct 2021 | Financial results | Financial Results for the Quarter Ended 30 September 2021 | |
| 15 Oct 2021 | Board meeting | Notice of Board Meeting (Q3-2021) | |
| 15 Sep 2021 | Restructuring | Mandatory Conversion of Physical Shares to Book-Entry Form | |
| 08 Sep 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 08 Sep 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | |
| 27 Aug 2021 | Report sent to shareholders | Transmission of Half-Yearly Report for the Period Ended 30 June 2021 | |
| 24 Aug 2021 | Financial results | Financial Result for the Quarter Ended 2021-06-30 | |
| 13 Aug 2021 | Board meeting | Notice of Board Meeting (Q2-2021) | |
| 05 May 2021 | Dividend or bonus payment | Credit of Final Cash Dividend - YE 31 Dec 2020 | |
| 04 May 2021 | Dividend | Prior Publication of Dividend Notice | |
| 30 Apr 2021 | Announcement | GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited | |
| 29 Apr 2021 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 31 March 2021 | |
| 23 Apr 2021 | Financial results | Financial Results for the Quarter Ended 2021-03-31 | |
| 22 Apr 2021 | General meeting | Resolution passed by the Shareholders in the Annual General Meeting. | |
| 16 Apr 2021 | Board meeting | Notice of Board Meeting (Q1-2021) | |
| 01 Apr 2021 | Management change | Change of Chief Executive Officer | |
| 31 Mar 2021 | Report sent to shareholders | Transmission of Annual Report for the Year Ended 2020 | |
| 31 Mar 2021 | General meeting | Notice of Annual General Meeting | |
| 30 Mar 2021 | General meeting | Prior Publication of AGM Notice | |
| 30 Mar 2021 | General meeting | Prior Publication of AGM Notice REVOKED | |
| 25 Mar 2021 | Book closure | Revised Book Closure | |
| 05 Mar 2021 | Financial results | Financial Results for the Year Ended December 31, 2020 | |
| 04 Mar 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 03 Mar 2021 | Management change | Appointment of Non-Executive Independent Director | |
| 01 Mar 2021 | Board meeting | Board Meeting - Q4-2020 | |
| 08 Feb 2021 | Material information | Material Information | |
| 04 Feb 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 01 Feb 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 01 Feb 2021 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | |
| 21 Dec 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 16 Dec 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 09 Dec 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 04 Dec 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 26 Nov 2020 | Corporate briefing | Corporate Briefing Session | |
| 29 Oct 2020 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30 September 2020 | |
| 27 Oct 2020 | Management change | Appointment of Non-Executive Director | |
| 27 Oct 2020 | Management change | Appointment of Chief Financial Officer and Executive Director | |
| 27 Oct 2020 | Financial results | Financial Results for the Quarter Ended 2020-09-30 | |
| 20 Oct 2020 | Board meeting | Board Meeting | |
| 31 Aug 2020 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30-06-2020 | |
| 28 Aug 2020 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30-06-2020 REVOKED | |
| 27 Aug 2020 | Management change | Appointment of Director | |
| 26 Aug 2020 | Financial results | Financial Results for the Quarter Ended - 2020-06-30 | |
| 19 Aug 2020 | Board meeting | Board Meeting | |
| 14 Jul 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 15 Jun 2020 | Dividend or bonus payment | Credit of Final Cash Dividend | |
| 12 Jun 2020 | Dividend | Prior Publication Notice (Dividend Credtit) | |
| 29 May 2020 | Report sent to shareholders | QUARTERLY REPORT Q1 2020 | |
| 29 May 2020 | Management change | Change of Company Secretary & Director | |
| 21 May 2020 | General meeting | Certified true copy of resolution | |
| 21 May 2020 | Announcement | Finacial Results Q1 2020 | |
| 13 May 2020 | Board meeting | Board Meeting Notice & Closed Period | |
| 04 May 2020 | Announcement | Purchase of Comapny Share by Spouse of the Company Executive | |
| 29 Apr 2020 | General meeting | NOTICE OF ANNUAL GENERAL MEETING 2019 | |
| 29 Apr 2020 | Report sent to shareholders | AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DEC 2019 |
Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
By kind
- Board meeting: 15
- General meeting: 14
- Shareholding disclosure: 14
- Report sent to shareholders: 13
- Financial results: 10
- Announcement: 9
- Management change: 8
- Corporate briefing: 4
- Restructuring: 4
- Material information: 3
- Dividend: 2
- Dividend or bonus payment: 2
- Administrative notice: 1
- Book closure: 1
Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
More on GSKCH
- GSKCH share price and overview
- Pharmaceuticals sector
- HALEON announcements · Haleon Pakistan Limited
- HINOON announcements · Highnoon Laboratories Limited
- HPL announcements · Hoechst Pakistan Limited
- GLAXO announcements · GlaxoSmithKline Pakistan Limited
- ABOT announcements · Abbott Laboratories (Pakistan) Limited
- SEARL announcements · The Searle Company Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .